| Literature DB >> 35075076 |
Musa Silahli1, Mehmet Tekin2, Ali Kal3, Mahmut Oguz Ulusoy4, Zeynel Gokmen5.
Abstract
BACKGROUND AND AIM: Retinopathy of prematurity (ROP), is a vasoprolipherative disorder of the immature retina and a major cause of preventable blindness in childhood. Although the development of ROP is multifactorial, the main reasons are lower gestational age and birth weight. However, in twins their gestational ages were the same, ROP development can be discordant. This study aims to evaluate the etiologic factors of discordant ROP development in twins.Entities:
Mesh:
Year: 2022 PMID: 35075076 PMCID: PMC8823591 DOI: 10.23750/abm.v92i6.11729
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203
Demographic properties of the Group 1 and Group 2
| Group1 (n=13) | Group2 (n=13) | P-value | |
|---|---|---|---|
|
| 7 (53) | 2(15) | .097 |
|
| 1010(700-1800) | 910(570- 1700) | .169 |
|
| 0(0-0) | 0(0-6) | .091 |
| 13,4 ± 7 | 19,5± 12 | .150 | |
| 36,7 ± 25 | 49,3± 30 | .266 | |
|
| 10(76) | 9(69) | 1 |
|
| 10(76) | 9(69) | 1 |
|
| 3(23) | 0 | .220 |
| 1(7) | 3(23) | .593 | |
|
| 6 (46) | 11(84) | .091 |
|
| 8(61) | 9(69) | 1 |
| 0 | 1(7) | 1 | |
|
| 4(30) | 9(69) | .115 |
|
| 17,3 ± 4 | 19,4 ± 7 | .435 |
| 217±116 | 164±137 | .348 | |
|
| 0(0-2) | 2(0-2) |
|
|
| 3 (23) | 0 | .220 |
|
| 1(7) | 4(30) | .322 |
|
| 1(7) | 2(15) | 1 |
Abbreviations: RDS: Respiratory distress syndrome, PDA: Patent ductus arteriosus, IVH: Intraventricular hemorrhage, BPD: Bronchopulmonary dysplasia, NEC: Necrotising enterocolitis, pRBC: Packed red blood cell, SGA: Small for gestational age.
ROP stages according to the groups
| Group1 | Group2 | P values | |
|---|---|---|---|
|
| 8 (100) | 0 | .002 |
| 12 (63) | 7 (36) | .073 | |
|
| 1 (14) | 6 (86) | .073 |
|
| 2(25) | 6 (75) | .202 |
|
| 2(25) | 6 (75) | .202 |
Abbreviations: ROP: Retinopathy of prematurity, Group 1: Mild disease or no, Group 2: Severe disease
Baseline characteristics of twins developing variable severity of ROP
| Group1 (mild or no) | Group2 (more severe) | ||||
|---|---|---|---|---|---|
| Gestational week | Birth weight (gram) | Stage | Birth weight | Stage | |
|
| 27 | 700 | No ROP | 710 | Stage 1 |
|
| 28 | 810 | Stage 1 | 1010 | Stage 3 + zone2 |
|
| 27 | 1060 | No ROP | 910 | Stage 3 + zone2 |
|
| 30 | 1800 | No ROP | 600 | Stage 1 |
|
| 25 | 940 | No ROP | 980 | Stage 1 |
|
| 28 | 820 | Stage 1 | 950 | stage 3 + zone 2 |
|
| 30 | 1660 | No ROP | 950 | Stage 1 |
|
| 30 | 1550 | No ROP | 1530 | Stage 2 + zone 2 |
|
| 32 | 1700 | No ROP | 1730 | Stage 1 |
|
| 25 | 1010 | No ROP | 910 | Stage 1 |
|
| 27 | 1020 | Stage 1 + | 570 | Stage 2 + zone 2 |
|
| 27 | 790 | Stage 2 + zone 2 | 820 | Stage 2+ zone1-2 |
|
| 28 | 1010 | Stage 1 | 860 | Stage 1 |
+: Plus disease, ROP: Retinopathy of prematurity
ROP stages and progression according to the birth weight discordance (15% discrepancy in birth weight)
| Discordant birth weight (5 pairs) (n=10) | No birth weight discordance (8 pairs) (n=16) | P value | |
|---|---|---|---|
|
| 2(20) | 6(37,5) | .420 |
|
| 3 (30) | 5(31,3) | .648 |
|
| 5 (62,5) | 5 (50) | .664 |
Abbreviations: ROP: Retinopathy of prematurity